FORM N-PX PROXY VOTING RECORD
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | COLUMN 9 | COLUMN 10 | COLUMN 11 | COLUMN 12 | COLUMN 13 | COLUMN 14 | COLUMN 15 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NAME OF ISSUER |
CUSIP | ISIN | FIGI | MEETING DATE | VOTE DESCRIPTION | VOTE CATEGORY | DESCRIPTION OF OTHER CATEGORY | VOTE SOURCE | SHARES VOTED | SHARES ON LOAN | DETAILS OF VOTE | MANAGER NUMBER | SERIES ID | OTHER INFO | ||
| HOW VOTED | SHARES VOTED | FOR OR AGAINST MANAGEMENT | ||||||||||||||
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 945624 | 0 | FOR |
945624 |
FOR |
1 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 945624 | 0 | FOR |
945624 |
FOR |
1 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 945624 | 0 | FOR |
945624 |
FOR |
1 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1373642 | 0 | FOR |
1373642 |
FOR |
1 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1373642 | 0 | FOR |
1373642 |
FOR |
1 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1373642 | 0 | FOR |
1373642 |
FOR |
1 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 945624 | 0 | FOR |
945624 |
FOR |
2 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 945624 | 0 | FOR |
945624 |
FOR |
2 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 945624 | 0 | FOR |
945624 |
FOR |
2 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1373642 | 0 | FOR |
1373642 |
FOR |
2 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1373642 | 0 | FOR |
1373642 |
FOR |
2 |
- | - |
| ABIVAX SA | 00370M103 | US00370M1036 | - | 05/30/2024 | Please see Exhibit A of the Depositary Notice of Combined General Meeting. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1373642 | 0 | FOR |
1373642 |
FOR |
2 |
- | - |
| AMICUS THERAPEUTICS, INC. | 03152W109 | US03152W1099 | - | 06/06/2024 | Approval, on a advisory basis, the Company's executive compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 568290 | 0 | ABSTAIN |
568290 |
AGAINST |
1 |
- | - |
| AMICUS THERAPEUTICS, INC. | 03152W109 | US03152W1099 | - | 06/06/2024 | Approval, on a advisory basis, the Company's executive compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 825516 | 0 | ABSTAIN |
825516 |
AGAINST |
1 |
- | - |
| AMICUS THERAPEUTICS, INC. | 03152W109 | US03152W1099 | - | 06/06/2024 | Approval, on a advisory basis, the Company's executive compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 568290 | 0 | ABSTAIN |
568290 |
AGAINST |
2 |
- | - |
| AMICUS THERAPEUTICS, INC. | 03152W109 | US03152W1099 | - | 06/06/2024 | Approval, on a advisory basis, the Company's executive compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 825516 | 0 | ABSTAIN |
825516 |
AGAINST |
2 |
- | - |
| ANAPTYSBIO, INC. | 032724106 | US0327241065 | - | 06/12/2024 | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 371253 | 0 | FOR |
371253 |
FOR |
1 |
- | - |
| ANAPTYSBIO, INC. | 032724106 | US0327241065 | - | 06/12/2024 | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 539293 | 0 | FOR |
539293 |
FOR |
1 |
- | - |
| ANAPTYSBIO, INC. | 032724106 | US0327241065 | - | 06/12/2024 | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 371253 | 0 | FOR |
371253 |
FOR |
2 |
- | - |
| ANAPTYSBIO, INC. | 032724106 | US0327241065 | - | 06/12/2024 | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 539293 | 0 | FOR |
539293 |
FOR |
2 |
- | - |
| ARCELLX, INC. | 03940C100 | US03940C1009 | - | 05/24/2024 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote") | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 114000 | 0 | FOR |
114000 |
FOR |
1 |
- | - |
| ARCELLX, INC. | 03940C100 | US03940C1009 | - | 05/24/2024 | To approve, on an advisory basis, the frequency of future Say-on-Pay Votes | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 114000 | 0 | 1 YEAR |
114000 |
FOR |
1 |
- | - |
| ARCELLX, INC. | 03940C100 | US03940C1009 | - | 05/24/2024 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote") | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 108437 | 0 | FOR |
108437 |
FOR |
1 |
- | - |
| ARCELLX, INC. | 03940C100 | US03940C1009 | - | 05/24/2024 | To approve, on an advisory basis, the frequency of future Say-on-Pay Votes | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 108437 | 0 | 1 YEAR |
108437 |
FOR |
1 |
- | - |
| ARCELLX, INC. | 03940C100 | US03940C1009 | - | 05/24/2024 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote") | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 114000 | 0 | FOR |
114000 |
FOR |
2 |
- | - |
| ARCELLX, INC. | 03940C100 | US03940C1009 | - | 05/24/2024 | To approve, on an advisory basis, the frequency of future Say-on-Pay Votes | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 114000 | 0 | 1 YEAR |
114000 |
FOR |
2 |
- | - |
| ARCELLX, INC. | 03940C100 | US03940C1009 | - | 05/24/2024 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote") | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 108437 | 0 | FOR |
108437 |
FOR |
2 |
- | - |
| ARCELLX, INC. | 03940C100 | US03940C1009 | - | 05/24/2024 | To approve, on an advisory basis, the frequency of future Say-on-Pay Votes | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 108437 | 0 | 1 YEAR |
108437 |
FOR |
2 |
- | - |
| ARVINAS, INC. | 04335A105 | US04335A1051 | - | 05/29/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 26251 | 0 | FOR |
26251 |
FOR |
1 |
- | - |
| ARVINAS, INC. | 04335A105 | US04335A1051 | - | 05/29/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 40960 | 0 | FOR |
40960 |
FOR |
1 |
- | - |
| ARVINAS, INC. | 04335A105 | US04335A1051 | - | 05/29/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 68 | 0 | FOR |
68 |
FOR |
1 |
- | - |
| ARVINAS, INC. | 04335A105 | US04335A1051 | - | 05/29/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 26251 | 0 | FOR |
26251 |
FOR |
2 |
- | - |
| ARVINAS, INC. | 04335A105 | US04335A1051 | - | 05/29/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 40960 | 0 | FOR |
40960 |
FOR |
2 |
- | - |
| ARVINAS, INC. | 04335A105 | US04335A1051 | - | 05/29/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 68 | 0 | FOR |
68 |
FOR |
2 |
- | - |
| AUTOLUS THERAPEUTICS PLC | 05280R100 | US05280R1005 | - | 06/28/2024 | To approve the Directors' remuneration report set out on pages 18 to 44 (inclusive) of the 2023 Annual Report and Accounts. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 889833 | 0 | FOR |
889833 |
FOR |
1 |
- | - |
| AUTOLUS THERAPEUTICS PLC | 05280R100 | US05280R1005 | - | 06/28/2024 | To approve the Directors' remuneration report set out on pages 18 to 44 (inclusive) of the 2023 Annual Report and Accounts. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1292600 | 0 | FOR |
1292600 |
FOR |
1 |
- | - |
| AUTOLUS THERAPEUTICS PLC | 05280R100 | US05280R1005 | - | 06/28/2024 | To approve the Directors' remuneration report set out on pages 18 to 44 (inclusive) of the 2023 Annual Report and Accounts. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 159234 | 0 | FOR |
159234 |
FOR |
1 |
- | - |
| AUTOLUS THERAPEUTICS PLC | 05280R100 | US05280R1005 | - | 06/28/2024 | To approve the Directors' remuneration report set out on pages 18 to 44 (inclusive) of the 2023 Annual Report and Accounts. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 889833 | 0 | FOR |
889833 |
FOR |
2 |
- | - |
| AUTOLUS THERAPEUTICS PLC | 05280R100 | US05280R1005 | - | 06/28/2024 | To approve the Directors' remuneration report set out on pages 18 to 44 (inclusive) of the 2023 Annual Report and Accounts. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1292600 | 0 | FOR |
1292600 |
FOR |
2 |
- | - |
| AUTOLUS THERAPEUTICS PLC | 05280R100 | US05280R1005 | - | 06/28/2024 | To approve the Directors' remuneration report set out on pages 18 to 44 (inclusive) of the 2023 Annual Report and Accounts. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 159234 | 0 | FOR |
159234 |
FOR |
2 |
- | - |
| CYTOKINETICS, INCORPORATED | 23282W605 | US23282W6057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 76861 | 0 | FOR |
76861 |
FOR |
1 |
- | - |
| CYTOKINETICS, INCORPORATED | 23282W605 | US23282W6057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 111565 | 0 | FOR |
111565 |
FOR |
1 |
- | - |
| CYTOKINETICS, INCORPORATED | 23282W605 | US23282W6057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 48 | 0 | FOR |
48 |
FOR |
1 |
- | - |
| CYTOKINETICS, INCORPORATED | 23282W605 | US23282W6057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 76861 | 0 | FOR |
76861 |
FOR |
2 |
- | - |
| CYTOKINETICS, INCORPORATED | 23282W605 | US23282W6057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 111565 | 0 | FOR |
111565 |
FOR |
2 |
- | - |
| CYTOKINETICS, INCORPORATED | 23282W605 | US23282W6057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 48 | 0 | FOR |
48 |
FOR |
2 |
- | - |
| DECIPHERA PHARMACEUTICALS, INC. | 24344T101 | US24344T1016 | - | 06/12/2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this notice. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 8782 | 0 | FOR |
8782 |
FOR |
1 |
- | - |
| DECIPHERA PHARMACEUTICALS, INC. | 24344T101 | US24344T1016 | - | 06/12/2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this notice. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 12757 | 0 | FOR |
12757 |
FOR |
1 |
- | - |
| DECIPHERA PHARMACEUTICALS, INC. | 24344T101 | US24344T1016 | - | 06/12/2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this notice. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1572 | 0 | FOR |
1572 |
FOR |
1 |
- | - |
| DECIPHERA PHARMACEUTICALS, INC. | 24344T101 | US24344T1016 | - | 06/12/2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this notice. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 8782 | 0 | FOR |
8782 |
FOR |
2 |
- | - |
| DECIPHERA PHARMACEUTICALS, INC. | 24344T101 | US24344T1016 | - | 06/12/2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this notice. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 12757 | 0 | FOR |
12757 |
FOR |
2 |
- | - |
| DECIPHERA PHARMACEUTICALS, INC. | 24344T101 | US24344T1016 | - | 06/12/2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this notice. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1572 | 0 | FOR |
1572 |
FOR |
2 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To approve, on an advisory basis, the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 237500 | 0 | FOR |
237500 |
FOR |
1 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To recommend, by an advisory, non-binding vote, the frequency of future advisory votes to approve the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 237500 | 0 | 1 YEAR |
237500 |
FOR |
1 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To approve, on an advisory basis, the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 345000 | 0 | FOR |
345000 |
FOR |
1 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To recommend, by an advisory, non-binding vote, the frequency of future advisory votes to approve the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 345000 | 0 | 1 YEAR |
345000 |
FOR |
1 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To approve, on an advisory basis, the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 42500 | 0 | FOR |
42500 |
FOR |
1 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To recommend, by an advisory, non-binding vote, the frequency of future advisory votes to approve the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 42500 | 0 | 1 YEAR |
42500 |
FOR |
1 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To approve, on an advisory basis, the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 237500 | 0 | FOR |
237500 |
FOR |
2 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To recommend, by an advisory, non-binding vote, the frequency of future advisory votes to approve the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 237500 | 0 | 1 YEAR |
237500 |
FOR |
2 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To approve, on an advisory basis, the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 345000 | 0 | FOR |
345000 |
FOR |
2 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To recommend, by an advisory, non-binding vote, the frequency of future advisory votes to approve the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 345000 | 0 | 1 YEAR |
345000 |
FOR |
2 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To approve, on an advisory basis, the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 42500 | 0 | FOR |
42500 |
FOR |
2 |
- | - |
| DIANTHUS THERAPEUTICS, INC. | 252828108 | US2528281080 | - | 05/23/2024 | To recommend, by an advisory, non-binding vote, the frequency of future advisory votes to approve the compensation paid to our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 42500 | 0 | 1 YEAR |
42500 |
FOR |
2 |
- | - |
| DYNAVAX TECHNOLOGIES CORPORATION | 268158201 | US2681582019 | - | 05/23/2024 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this Notice | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 129646 | 0 | FOR |
129646 |
FOR |
1 |
- | - |
| DYNAVAX TECHNOLOGIES CORPORATION | 268158201 | US2681582019 | - | 05/23/2024 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this Notice | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 188328 | 0 | FOR |
188328 |
FOR |
1 |
- | - |
| DYNAVAX TECHNOLOGIES CORPORATION | 268158201 | US2681582019 | - | 05/23/2024 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this Notice | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 129646 | 0 | FOR |
129646 |
FOR |
2 |
- | - |
| DYNAVAX TECHNOLOGIES CORPORATION | 268158201 | US2681582019 | - | 05/23/2024 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this Notice | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 188328 | 0 | FOR |
188328 |
FOR |
2 |
- | - |
| ESPERION THERAPEUTICS, INC. | 29664W105 | US29664W1053 | - | 05/23/2024 | To approve the non-binding advisory resolution on the compensation of our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 3040000 | 0 | FOR |
3040000 |
FOR |
1 |
- | - |
| ESPERION THERAPEUTICS, INC. | 29664W105 | US29664W1053 | - | 05/23/2024 | To approve the non-binding advisory resolution on the compensation of our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 4416000 | 0 | FOR |
4416000 |
FOR |
1 |
- | - |
| ESPERION THERAPEUTICS, INC. | 29664W105 | US29664W1053 | - | 05/23/2024 | To approve the non-binding advisory resolution on the compensation of our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 3040000 | 0 | FOR |
3040000 |
FOR |
2 |
- | - |
| ESPERION THERAPEUTICS, INC. | 29664W105 | US29664W1053 | - | 05/23/2024 | To approve the non-binding advisory resolution on the compensation of our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 4416000 | 0 | FOR |
4416000 |
FOR |
2 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 931000 | 0 | FOR |
931000 |
FOR |
1 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 931000 | 0 | 1 YEAR |
931000 |
FOR |
1 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1352400 | 0 | FOR |
1352400 |
FOR |
1 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1352400 | 0 | 1 YEAR |
1352400 |
FOR |
1 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 586 | 0 | FOR |
586 |
FOR |
1 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 586 | 0 | 1 YEAR |
586 |
FOR |
1 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 931000 | 0 | FOR |
931000 |
FOR |
2 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 931000 | 0 | 1 YEAR |
931000 |
FOR |
2 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1352400 | 0 | FOR |
1352400 |
FOR |
2 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1352400 | 0 | 1 YEAR |
1352400 |
FOR |
2 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 586 | 0 | FOR |
586 |
FOR |
2 |
- | - |
| EVOLUS, INC. | 30052C107 | US30052C1071 | - | 06/06/2024 | Approval of, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of Evolus' named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 586 | 0 | 1 YEAR |
586 |
FOR |
2 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. | COMPENSATION |
- | ISSUER | 43700 | 0 | FOR |
43700 |
FOR |
1 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers. | COMPENSATION |
- | ISSUER | 43700 | 0 | 1 YEAR |
43700 |
FOR |
1 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To approve the directors' remuneration report for the year ended December 31, 2023, which is set forth as Annex A to the proxy statement and on pages 20 to 47 (inclusive) of the 2023 U.K. Annual Report. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 43700 | 0 | FOR |
43700 |
FOR |
1 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 63480 | 0 | FOR |
63480 |
FOR |
1 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 63480 | 0 | 1 YEAR |
63480 |
FOR |
1 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To approve the directors' remuneration report for the year ended December 31, 2023, which is set forth as Annex A to the proxy statement and on pages 20 to 47 (inclusive) of the 2023 U.K. Annual Report. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 63480 | 0 | FOR |
63480 |
FOR |
1 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. | COMPENSATION |
- | ISSUER | 43700 | 0 | FOR |
43700 |
FOR |
2 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers. | COMPENSATION |
- | ISSUER | 43700 | 0 | 1 YEAR |
43700 |
FOR |
2 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To approve the directors' remuneration report for the year ended December 31, 2023, which is set forth as Annex A to the proxy statement and on pages 20 to 47 (inclusive) of the 2023 U.K. Annual Report. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 43700 | 0 | FOR |
43700 |
FOR |
2 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 63480 | 0 | FOR |
63480 |
FOR |
2 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 63480 | 0 | 1 YEAR |
63480 |
FOR |
2 |
- | - |
| IMMUNOCORE HOLDINGS PLC | 45258D105 | US45258D1054 | - | 05/23/2024 | To approve the directors' remuneration report for the year ended December 31, 2023, which is set forth as Annex A to the proxy statement and on pages 20 to 47 (inclusive) of the 2023 U.K. Annual Report. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 63480 | 0 | FOR |
63480 |
FOR |
2 |
- | - |
| INSMED INCORPORATED | 457669307 | US4576693075 | - | 05/13/2024 | An advisory vote on the 2023 compensation of our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 294501 | 0 | FOR |
294501 |
FOR |
1 |
- | - |
| INSMED INCORPORATED | 457669307 | US4576693075 | - | 05/13/2024 | An advisory vote on the 2023 compensation of our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 427800 | 0 | FOR |
427800 |
FOR |
1 |
- | - |
| INSMED INCORPORATED | 457669307 | US4576693075 | - | 05/13/2024 | An advisory vote on the 2023 compensation of our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 294501 | 0 | FOR |
294501 |
FOR |
2 |
- | - |
| INSMED INCORPORATED | 457669307 | US4576693075 | - | 05/13/2024 | An advisory vote on the 2023 compensation of our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 427800 | 0 | FOR |
427800 |
FOR |
2 |
- | - |
| IVERIC BIO, INC. | 46583P102 | US46583P1021 | - | 07/06/2023 | To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 243750 | 0 | FOR |
243750 |
FOR |
1 |
- | - |
| IVERIC BIO, INC. | 46583P102 | US46583P1021 | - | 07/06/2023 | To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 350000 | 0 | FOR |
350000 |
FOR |
1 |
- | - |
| IVERIC BIO, INC. | 46583P102 | US46583P1021 | - | 07/06/2023 | To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 31250 | 0 | FOR |
31250 |
FOR |
1 |
- | - |
| IVERIC BIO, INC. | 46583P102 | US46583P1021 | - | 07/06/2023 | To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 243750 | 0 | FOR |
243750 |
FOR |
2 |
- | - |
| IVERIC BIO, INC. | 46583P102 | US46583P1021 | - | 07/06/2023 | To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 350000 | 0 | FOR |
350000 |
FOR |
2 |
- | - |
| IVERIC BIO, INC. | 46583P102 | US46583P1021 | - | 07/06/2023 | To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 31250 | 0 | FOR |
31250 |
FOR |
2 |
- | - |
| JAZZ PHARMACEUTICALS PLC | G50871105 | IE00B4Q5ZN47 | - | 08/03/2023 | To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 47969 | 0 | FOR |
47969 |
FOR |
1 |
- | - |
| JAZZ PHARMACEUTICALS PLC | G50871105 | IE00B4Q5ZN47 | - | 08/03/2023 | To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 68878 | 0 | FOR |
68878 |
FOR |
1 |
- | - |
| JAZZ PHARMACEUTICALS PLC | G50871105 | IE00B4Q5ZN47 | - | 08/03/2023 | To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 6151 | 0 | FOR |
6151 |
FOR |
1 |
- | - |
| JAZZ PHARMACEUTICALS PLC | G50871105 | IE00B4Q5ZN47 | - | 08/03/2023 | To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 47969 | 0 | FOR |
47969 |
FOR |
2 |
- | - |
| JAZZ PHARMACEUTICALS PLC | G50871105 | IE00B4Q5ZN47 | - | 08/03/2023 | To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 68878 | 0 | FOR |
68878 |
FOR |
2 |
- | - |
| JAZZ PHARMACEUTICALS PLC | G50871105 | IE00B4Q5ZN47 | - | 08/03/2023 | To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 6151 | 0 | FOR |
6151 |
FOR |
2 |
- | - |
| LEXICON PHARMACEUTICALS, INC. | 528872302 | US5288723027 | - | 05/10/2024 | Advisory vote to approve the compensation paid to the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 35023 | 0 | FOR |
35023 |
FOR |
1 |
- | - |
| LEXICON PHARMACEUTICALS, INC. | 528872302 | US5288723027 | - | 05/10/2024 | Advisory vote to approve the compensation paid to the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 50875 | 0 | FOR |
50875 |
FOR |
1 |
- | - |
| LEXICON PHARMACEUTICALS, INC. | 528872302 | US5288723027 | - | 05/10/2024 | Advisory vote to approve the compensation paid to the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 6267 | 0 | FOR |
6267 |
FOR |
1 |
- | - |
| LEXICON PHARMACEUTICALS, INC. | 528872302 | US5288723027 | - | 05/10/2024 | Advisory vote to approve the compensation paid to the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 35023 | 0 | FOR |
35023 |
FOR |
2 |
- | - |
| LEXICON PHARMACEUTICALS, INC. | 528872302 | US5288723027 | - | 05/10/2024 | Advisory vote to approve the compensation paid to the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 50875 | 0 | FOR |
50875 |
FOR |
2 |
- | - |
| LEXICON PHARMACEUTICALS, INC. | 528872302 | US5288723027 | - | 05/10/2024 | Advisory vote to approve the compensation paid to the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 6267 | 0 | FOR |
6267 |
FOR |
2 |
- | - |
| MERUS N.V. | N5749R100 | NL0011606264 | - | 05/07/2024 | Approval, on an Advisory (Non-Binding) basis, of the compensation of Merus N.V.'s named Executive Officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 84849 | 0 | FOR |
84849 |
FOR |
1 |
- | - |
| MERUS N.V. | N5749R100 | NL0011606264 | - | 05/07/2024 | Approval, on an Advisory (Non-Binding) basis, of the compensation of Merus N.V.'s named Executive Officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 123255 | 0 | FOR |
123255 |
FOR |
1 |
- | - |
| MERUS N.V. | N5749R100 | NL0011606264 | - | 05/07/2024 | Approval, on an Advisory (Non-Binding) basis, of the compensation of Merus N.V.'s named Executive Officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 84849 | 0 | FOR |
84849 |
FOR |
2 |
- | - |
| MERUS N.V. | N5749R100 | NL0011606264 | - | 05/07/2024 | Approval, on an Advisory (Non-Binding) basis, of the compensation of Merus N.V.'s named Executive Officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 123255 | 0 | FOR |
123255 |
FOR |
2 |
- | - |
| NEUROGENE INC. | 64135M105 | US64135M1053 | - | 06/14/2024 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 381631 | 0 | FOR |
381631 |
FOR |
1 |
- | - |
| NEUROGENE INC. | 64135M105 | US64135M1053 | - | 06/14/2024 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 554368 | 0 | FOR |
554368 |
FOR |
1 |
- | - |
| NEUROGENE INC. | 64135M105 | US64135M1053 | - | 06/14/2024 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 65907 | 0 | FOR |
65907 |
FOR |
1 |
- | - |
| NEUROGENE INC. | 64135M105 | US64135M1053 | - | 06/14/2024 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 381631 | 0 | FOR |
381631 |
FOR |
2 |
- | - |
| NEUROGENE INC. | 64135M105 | US64135M1053 | - | 06/14/2024 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 554368 | 0 | FOR |
554368 |
FOR |
2 |
- | - |
| NEUROGENE INC. | 64135M105 | US64135M1053 | - | 06/14/2024 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 65907 | 0 | FOR |
65907 |
FOR |
2 |
- | - |
| OCULAR THERAPEUTIX, INC. | 67576A100 | US67576A1007 | - | 06/12/2024 | To approve an advisory vote on named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 656915 | 0 | FOR |
656915 |
FOR |
1 |
- | - |
| OCULAR THERAPEUTIX, INC. | 67576A100 | US67576A1007 | - | 06/12/2024 | To approve an advisory vote on named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 954255 | 0 | FOR |
954255 |
FOR |
1 |
- | - |
| OCULAR THERAPEUTIX, INC. | 67576A100 | US67576A1007 | - | 06/12/2024 | To approve an advisory vote on named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 117553 | 0 | FOR |
117553 |
FOR |
1 |
- | - |
| OCULAR THERAPEUTIX, INC. | 67576A100 | US67576A1007 | - | 06/12/2024 | To approve an advisory vote on named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 656915 | 0 | FOR |
656915 |
FOR |
2 |
- | - |
| OCULAR THERAPEUTIX, INC. | 67576A100 | US67576A1007 | - | 06/12/2024 | To approve an advisory vote on named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 954255 | 0 | FOR |
954255 |
FOR |
2 |
- | - |
| OCULAR THERAPEUTIX, INC. | 67576A100 | US67576A1007 | - | 06/12/2024 | To approve an advisory vote on named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 117553 | 0 | FOR |
117553 |
FOR |
2 |
- | - |
| OPTINOSE, INC. | 68404V100 | US68404V1008 | - | 06/06/2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 3338801 | 0 | FOR |
3338801 |
FOR |
1 |
- | - |
| OPTINOSE, INC. | 68404V100 | US68404V1008 | - | 06/06/2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 4850047 | 0 | FOR |
4850047 |
FOR |
1 |
- | - |
| OPTINOSE, INC. | 68404V100 | US68404V1008 | - | 06/06/2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 3338801 | 0 | FOR |
3338801 |
FOR |
2 |
- | - |
| OPTINOSE, INC. | 68404V100 | US68404V1008 | - | 06/06/2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 4850047 | 0 | FOR |
4850047 |
FOR |
2 |
- | - |
| PHARMING GROUP NV | N69603145 | NL0010391025 | - | 05/21/2024 | ANNUAL REPORT 2023: REMUNERATION REPORT FOR 2023 | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 3876000 | 0 | FOR |
3876000 |
FOR |
1 |
- | - |
| PHARMING GROUP NV | N69603145 | NL0010391025 | - | 05/21/2024 | ANNUAL REPORT 2023: REMUNERATION REPORT FOR 2023 | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 5630400 | 0 | FOR |
5630400 |
FOR |
1 |
- | - |
| PHARMING GROUP NV | N69603145 | NL0010391025 | - | 05/21/2024 | ANNUAL REPORT 2023: REMUNERATION REPORT FOR 2023 | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 161178 | 0 | FOR |
161178 |
FOR |
1 |
- | - |
| PHARMING GROUP NV | N69603145 | NL0010391025 | - | 05/21/2024 | ANNUAL REPORT 2023: REMUNERATION REPORT FOR 2023 | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 3876000 | 0 | FOR |
3876000 |
FOR |
2 |
- | - |
| PHARMING GROUP NV | N69603145 | NL0010391025 | - | 05/21/2024 | ANNUAL REPORT 2023: REMUNERATION REPORT FOR 2023 | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 5630400 | 0 | FOR |
5630400 |
FOR |
2 |
- | - |
| PHARMING GROUP NV | N69603145 | NL0010391025 | - | 05/21/2024 | ANNUAL REPORT 2023: REMUNERATION REPORT FOR 2023 | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 161178 | 0 | FOR |
161178 |
FOR |
2 |
- | - |
| PLIANT THERAPEUTICS, INC. | 729139105 | US7291391057 | - | 06/13/2024 | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 703708 | 0 | FOR |
703708 |
FOR |
1 |
- | - |
| PLIANT THERAPEUTICS, INC. | 729139105 | US7291391057 | - | 06/13/2024 | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1022228 | 0 | FOR |
1022228 |
FOR |
1 |
- | - |
| PLIANT THERAPEUTICS, INC. | 729139105 | US7291391057 | - | 06/13/2024 | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 703708 | 0 | FOR |
703708 |
FOR |
2 |
- | - |
| PLIANT THERAPEUTICS, INC. | 729139105 | US7291391057 | - | 06/13/2024 | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1022228 | 0 | FOR |
1022228 |
FOR |
2 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement (''say-on-pay vote'') | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 595944 | 0 | FOR |
595944 |
FOR |
1 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote regarding the frequency of future say-on-pay votes | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 595944 | 0 | 1 YEAR |
595944 |
FOR |
1 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement (''say-on-pay vote'') | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 865686 | 0 | FOR |
865686 |
FOR |
1 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote regarding the frequency of future say-on-pay votes | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 865686 | 0 | 1 YEAR |
865686 |
FOR |
1 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement (''say-on-pay vote'') | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 3090 | 0 | FOR |
3090 |
FOR |
1 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote regarding the frequency of future say-on-pay votes | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 3090 | 0 | 1 YEAR |
3090 |
FOR |
1 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement (''say-on-pay vote'') | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 595944 | 0 | FOR |
595944 |
FOR |
2 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote regarding the frequency of future say-on-pay votes | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 595944 | 0 | 1 YEAR |
595944 |
FOR |
2 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement (''say-on-pay vote'') | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 865686 | 0 | FOR |
865686 |
FOR |
2 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote regarding the frequency of future say-on-pay votes | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 865686 | 0 | 1 YEAR |
865686 |
FOR |
2 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement (''say-on-pay vote'') | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 3090 | 0 | FOR |
3090 |
FOR |
2 |
- | - |
| PUMA BIOTECHNOLOGY, INC. | 74587V107 | US74587V1070 | - | 06/18/2024 | Advisory (non-binding) vote regarding the frequency of future say-on-pay votes | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 3090 | 0 | 1 YEAR |
3090 |
FOR |
2 |
- | - |
| UROGEN PHARMA LTD | M96088105 | IL0011407140 | - | 09/07/2023 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement for the Annual Meeting | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 969602 | 0 | FOR |
969602 |
FOR |
1 |
- | - |
| UROGEN PHARMA LTD | M96088105 | IL0011407140 | - | 09/07/2023 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement for the Annual Meeting | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1467505 | 0 | FOR |
1467505 |
FOR |
1 |
- | - |
| UROGEN PHARMA LTD | M96088105 | IL0011407140 | - | 09/07/2023 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement for the Annual Meeting | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 183438 | 0 | FOR |
183438 |
FOR |
1 |
- | - |
| UROGEN PHARMA LTD | M96088105 | IL0011407140 | - | 09/07/2023 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement for the Annual Meeting | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 969602 | 0 | FOR |
969602 |
FOR |
2 |
- | - |
| UROGEN PHARMA LTD | M96088105 | IL0011407140 | - | 09/07/2023 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement for the Annual Meeting | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 1467505 | 0 | FOR |
1467505 |
FOR |
2 |
- | - |
| UROGEN PHARMA LTD | M96088105 | IL0011407140 | - | 09/07/2023 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement for the Annual Meeting | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 183438 | 0 | FOR |
183438 |
FOR |
2 |
- | - |
| VIRIDIAN THERAPEUTICS, INC. | 92790C104 | US92790C1045 | - | 06/17/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 524400 | 0 | FOR |
524400 |
FOR |
1 |
- | - |
| VIRIDIAN THERAPEUTICS, INC. | 92790C104 | US92790C1045 | - | 06/17/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 761760 | 0 | FOR |
761760 |
FOR |
1 |
- | - |
| VIRIDIAN THERAPEUTICS, INC. | 92790C104 | US92790C1045 | - | 06/17/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 524400 | 0 | FOR |
524400 |
FOR |
2 |
- | - |
| VIRIDIAN THERAPEUTICS, INC. | 92790C104 | US92790C1045 | - | 06/17/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 761760 | 0 | FOR |
761760 |
FOR |
2 |
- | - |
| XENON PHARMACEUTICALS INC | 98420N105 | CA98420N1050 | - | 06/04/2024 | Compensation of Named Executive Officers: Approve, on an advisory basis, the compensation of the Corporation's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 173335 | 0 | FOR |
173335 |
FOR |
1 |
- | - |
| XENON PHARMACEUTICALS INC | 98420N105 | CA98420N1050 | - | 06/04/2024 | Compensation of Named Executive Officers: Approve, on an advisory basis, the compensation of the Corporation's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 251794 | 0 | FOR |
251794 |
FOR |
1 |
- | - |
| XENON PHARMACEUTICALS INC | 98420N105 | CA98420N1050 | - | 06/04/2024 | Compensation of Named Executive Officers: Approve, on an advisory basis, the compensation of the Corporation's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 173335 | 0 | FOR |
173335 |
FOR |
2 |
- | - |
| XENON PHARMACEUTICALS INC | 98420N105 | CA98420N1050 | - | 06/04/2024 | Compensation of Named Executive Officers: Approve, on an advisory basis, the compensation of the Corporation's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | ISSUER | 251794 | 0 | FOR |
251794 |
FOR |
2 |
- | - |
[Repeat as Necessary]